Publication | Closed Access

Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice

Stress HormonePsychiatryBehavioral NeurosciencePsychotropic MedicationBehavioural PharmacologyReceptor AntagonistsPsychopharmacologyDepressionPsychologyNeuropharmacologyPrefrontal Dopaminergic AlterationsSocial SciencesNeuroscienceBiological PsychiatryMetabotropic Glutamate 2/3DopamineMedicinePsychopathology